Adverse Maternal and Fetal/Neonatal Outcomes:
All women in both LVOTO/AS and control groups were asymptomatic at baseline. There were no adverse maternal cardiac outcomes in the LVOTO/AS group (Table 4). Two women in the control group had supraventricular tachycardia during 2nd trimester of their pregnancy (Table 4). Obstetrical outcomes were similar between the two groups, although a trend to increased rate of gestational hypertension, miscarriage, and pre-term deliveries were observed. Three adverse fetal events occurred in the LVOTO/AS group and none in the control group (Table 4).